iVIGA Ketok Panyadia Pabrik
Tilu Téknologi Kaséhatan Detéksi Toilét Ieu Bakal Diuji Klinis Di AS, Israel Jeung Jepang
Israeli digital health startup OutSense has been awarded a number of patents for key innovations in IoT technology, according to foreign media reports on 23 Juni. The technology gains life-saving medical insights by analysing human excrement. Pausahaan geus Filed runtuyan tilu patén-patén ngawengku unsur sénsor toilet médis na.
Three Toilets Detection Health Technologies
The first OutSense toilets detection health technologies is for the detection of blood hidden in the toilet bowl. This OutSense device uses reflected light from the toilet to determine the optical signature of hidden blood in faeces. Patents for this technology have been granted in the US, Éropa, Jepang jeung Cina.
A second toilets detection health technologies has been granted in Europe and applications for this patent are pending in other countries. It allows effective analysis of the many components of faeces and the spatial distribution of blood traces. On the basis of this analysis, Téknologi OutSense tiasa ngaidentipikasi sumber getih sapanjang saluran pencernaan.
A third patent is pending for a technology that detects the dehydrated composition of urine through the analysis of urine and faeces.
Numutkeun CEO OutSense Yfat Scialom, who predicts that “kalayan ledakan ubar digital, this kind of monitoring will become the norm”, OutSense says that the technology already approved and pending approval will provide broad protection for a person’s health by non-invasively extracting faeces and hidden blood from the urine. Hidden blood is essential for detecting colorectal cancer, kasakit radang bowel jeung inféksi saluran kemih.
Its solution consists of a multispectral optical sensor, sumber cahaya sareng alat saringan otonom anu kalebet sambungan WiFi. The device scans human excrement, identifies the optical footprint of faecal and urine components, sends the data to an AI-based cloud analysis and then provides indications of various diseases with great precision.
OutSense has developed tools to diagnose abnormalities in human excreta. Inpormasi anu dicandak tina sampel getih, digabungkeun jeung analisis tambahan waktu ti perdarahan nepi ka ékskrési, nyadiakeun rinci ngeunaan patologi perdarahan. Its specific patterns can determine whether the bleeding is from a fissure or haemorrhoid, from a polyp, a tumour or from an ulcer.
Dina awal Juni, OutSense ngumumkeun yén CommuniCare, hiji parusahaan Podomoro badag kalayan leuwih ti 90 healthcare facilities in the US, bakal ngamimitian piloting téhnologi na taun ieu. Salian pilot ieu, OutSense also plans to conduct clinical trials in Israel and Japan.
Didatangan More News di Viga.cc News
